Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile
Craig Wallington-Gates

@craigthomaswb

Professor of Haematology, Griffith University
Director of Haematology, Sunshine Coast Hospital and Health Service

ID: 1119515947260231687

calendar_today20-04-2019 08:19:36

22 Tweet

94 Followers

25 Following

National Geographic (@natgeo) 's Twitter Profile Photo

Mysterious fossils discovered decades ago in Kenya represent a giant meat-eating mammal with fearsome teeth on.natgeo.com/2UMI4Ov

Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

ASH 2019 Orlando. The myeloma world is rapidly moving to BiTEs and CARTs. Australian sites need to prepare themselves for these therapies. Time to educate staff, mobilise resources and support these new trials coming through.

Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

#ASH2019 great demonstration by Philippe Moreau in the Cassiopeia trial that marrow MRD and PET imaging have poor correlation when assessing treatment response post consolidation. Both provide complementary info. If either are positive despite achieving CR, outcomes are inferior.

#ASH2019 great demonstration by Philippe Moreau in the Cassiopeia trial that marrow MRD and PET imaging have poor correlation when assessing treatment response post consolidation. Both provide complementary info. If either are positive despite achieving CR, outcomes are inferior.
International Space Station (@space_station) 's Twitter Profile Photo

Wildfires are pictured surrounding Sydney, Australia, as the International Space Station orbited 269 miles above the Tasman Sea on Jan. 3, 2020.

Wildfires are pictured surrounding Sydney, Australia, as the International Space Station orbited 269 miles above the Tasman Sea on Jan. 3, 2020.
Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells pubs.acs.org/doi/10.1021/ac…

UniSA (@universitysa) 's Twitter Profile Photo

New UniSA Research from Claudine Bonder Stuart Pitson and Flinders University haemotologist Craig Wallington-Gates will help advance treatment options for patients with aggressive #multiplemyeloma, the second most common blood cancer in the world.ow.ly/LCbX50DTBVn

New <a href="/unisaresearch/">UniSA Research</a> from <a href="/claudine_bonder/">Claudine Bonder</a> <a href="/s_pitson/">Stuart Pitson</a> and <a href="/Flinders/">Flinders University</a> haemotologist <a href="/CraigThomasWB/">Craig Wallington-Gates</a> will help advance treatment options for patients with aggressive #multiplemyeloma, the second most common blood cancer in the world.ow.ly/LCbX50DTBVn
Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

Leconfield Wines McLaren Vale Marathon : Make a donation today to support Leconfield Wines McLaren Vale Marathon to raise funds for multiple myeloma research. leconfieldmarathon.raisely.com/haematologyres… #leconfieldmarathon via Raisely

Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16‐02 trial onlinelibrary.wiley.com/doi/10.1111/bj…

Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

FEBS Press febs.onlinelibrary.wiley.com/doi/abs/10.100… We have finally published the prognostic importance of DSG2 in multiple myeloma. Congratulations to all who have contribute to this important work!!!

Paperbirds_Hematology (@paperbirdsm) 's Twitter Profile Photo

New article: Prognostic and predictive biomarker developments in multiple myeloma link.paperbirds.me/S8D7S4 #MMSM #MultipleMyeloma #hematology

New article: Prognostic and predictive biomarker developments in multiple myeloma link.paperbirds.me/S8D7S4 #MMSM #MultipleMyeloma #hematology
Craig Wallington-Gates (@craigthomaswb) 's Twitter Profile Photo

Just published a myeloma biomarker review "prognostic and predictive biomarker developments in multiple myeloma" in J Hematol Oncol which I hope will be useful to clinicians and researchers. rdcu.be/cyue9